Atrial Fibrillation Market to Witness Promising Growth Opportunities by 2024-2035
The Atrial Fibrillation Market—spanning pharmacological antiarrhythmics, direct oral anticoagulants (DOACs), catheter ablation devices, and left atrial appendage closure (LAAC) systems—is experiencing robust growth driven by an aging global population and rising cardiovascular disease incidence. As electrophysiologists adopt innovative non-thermal ablation modalities, such as Pulsed Field Ablation (PFA), the market is shifting toward safer, faster, and more durable rhythm control and stroke prevention interventions.
Read More: https://www.rootsanalysis.com/....reports/atrial-fibri